We serve Chemical Name:1-(bromomethyl)-4-(difluoromethylsulfonyl)benzene CAS:885529-55-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(bromomethyl)-4-(difluoromethylsulfonyl)benzene
CAS.NO:885529-55-5
Synonyms:1-(Bromomethyl)-4-[(difluoromethyl)sulfonyl]benzene;RW1165
Molecular Formula:C8H7BrF2O2S
Molecular Weight:285.10600
HS Code:2904909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:42.52000
Exact Mass:283.93200
LogP:3.65860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(Bromomethyl)-4-[(difluoromethyl)sulfonyl]benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,RW1165 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(Bromomethyl)-4-[(difluoromethyl)sulfonyl]benzene Use and application,RW1165 technical grade,usp/ep/jp grade.
Related News: As currently constituted, Vanamali employs roughly 140 works in Hyderabad, Telangana, that specialize in API starting materials and contract research, according to its website. Wavelength said the Indian firm currently sports enough capacity for research- to commercial-scale production of its drug intermediates. 2-(5-(([2,2′-bithiophen]-5-ylmethyl)amino)-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-1-(3,5-difluorophenyl)-3-phenylpropane-1,3-dione manufacturers J&J’s shot generates roughly 8 GBS cases per million vaccinated people, far higher than just a single case reported per million among mRNA recipients, CDC reported. 3,4,5-tris[(2S)-2-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)propoxy]benzoic acid suppliers The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. (1,1-dioxo-2,3-dihydro-1H-1λ6-benzo[1,4]thiazin-4-yl)-(5-nitro-furan-2-ylmethylene)-amine vendor & factory.
